SRPT - Sarepta Elevidys accelerated approval criticized by ICER exec
2024-05-02 15:36:47 ET
More on Sarepta Therapeutics
- Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Call Transcript
- Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy
- Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts
- Sarepta Therapeutics jumps 5% on Q1 beats
- Sarepta Therapeutics Q1 2024 Earnings Preview